Loading company…
Tentarix develops multifunctional biologics for oncology and immunology using its Tentacles platform.
Tentarix develops conditionally active, multispecific biologics for cancer and immune-related diseases using its Tentacles platform. It works with healthcare providers, research institutions, and pharmaceutical companies. Founded in 2020 and based in San Diego, the company raised USD 35.00 mn in Series B funding in August 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in